Inspired by electric rays that generate high voltages through stacked electrocytes, researchers at UNIST have developed a ...
This forms a "recursive feedback loop," whereby AI models design the next generation of chips and those chips, in turn, train ...
Ricursive Intelligence, a frontier AI lab founded by the co-creators of AlphaChip, today announced a $300 million Series A funding round led by Lightspeed Venture Partners at a $4 billion post-money ...
Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...
Node.js released updates fixing a critical DoS flaw caused by async_hooks stack crashes, tracked as CVE-2025-59466, impacting most production apps.
Nvidia is turning its AI firepower toward the hardest problems in medicine, striking multibillion-dollar alliances with pharmaceutical and biotech heavyweights to rewire how drugs are discovered and ...
The number of questions on Stack Overflow fell by 78 percent in December 2025 compared to a year earlier. Developers are switching en masse to AI tools in their IDEs, making the popular developer ...
is editor-in-chief of The Verge, host of the Decoder podcast, and co-host of The Vergecast. Today, I’m talking with Prashanth Chandrasekar, who is the CEO of Stack Overflow. I last had Prashanth on ...
Clang keeps a large fixed-size local array in the stack frame of a recursive function alive across recursive calls, even though the array is only used after both recursive calls return and its address ...
Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...
The release of .NET 10 brings with it F# version 10. It’s a refinement‑focused update that enhances the language’s ergonomics, improves performance, and optimises compiler behaviour for everyday ...
Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...